Daily non-political popular news in brief.

Why is long-term therapy required to cure tuberculosis?

Understanding why other bacteria become resistant to antibiotics could hold the key to understanding why TB takes so long to cure, say researchers in a policy paper in PLoS Medicine.

Read more »

Keywords: long-term, therapy, required, cure, tuberculosis, long, term, tuberculosi

« Previous | Next »

Similar news on "Why is long-term therapy required to cure tuberculosis?":

1. Keeping cancer at bay: Long-term therapy in the fight against multiple myeloma
   11-03-2006 · EurekAlert!
   There is no known cure for multiple myeloma, so its diagnosis means high-dose chemotherapy followed by repeated treatments with each relapse of the cancer -- a watch and wait approach. A new approach of providing patients with continuous therapy to keep the cancer at bay was explored by a team of international researchers from France, Switzerland and Belgium. Their findings will be published in the Nov. 15, 2006, issue of Blood.
   Similar news · Read more »
   
2. HIV persists in the gut despite long-term HIV therapy
   02-13-2008 · EurekAlert!
   Because of the importance of the gut to HIV disease, scientists hoped that long-term treatment with antiretroviral drugs could eradicate HIV from the GALT. A new NIAID study, published online by The Journal of Infectious Diseases, has found that this goal seems unlikely with current antiretroviral drugs.
   Similar news · Read more »
   
3. Antibody reduces incidence of acute rejection in high-risk kidney transplant patients
   11-08-2006 · EurekAlert!
   Nearly 70 percent of kidney transplant patients get short-term drug therapy initially administered during surgery to help prevent rejection. In the first direct comparison of the two drugs most commonly given to ward off acute kidney rejection, an international study led by Washington University School of Medicine in St. Louis shows that one -- anti-thymocyte globulin -- is superior. The results also suggest the drug could potentially save millions of dollars in health care costs.
   Similar news · Read more »
   
4. Angioplasty reduces long-term cardiac risk among heart patients with 'silent' ischemia
   05-08-2007 · EurekAlert!
   When compared with intensive drug therapy, percutaneous coronary intervention (PCI, angioplasty) was more beneficial in reducing the long-term risk of major cardiac events among heart attack survivors with "silent ischemia," according to a study in the May 9 issue of JAMA.
   Similar news · Read more »
   
5. Just 4 months of hormone therapy can delay prostate cancer growth by up to 8 years
   01-02-2008 · EurekAlert!
   Researchers report that just four months of hormonal therapy before and with standard external beam radiation therapy slowed cancer growth by as much as eight years -- especially the development of bone metastases -- and increased survival in older men with potentially aggressive prostate cancer. This "neoadjuvant" hormonal therapy may allow men most at risk of developing bone metastases avoid long-term hormonal therapy later on.
   Similar news · Read more »
   
6. Experimental MS drug shows promise, offers new window on disease
   02-13-2008 · EurekAlert!
   A drug therapy currently used to treat non-Hodgkin's lymphoma and rheumatoid arthritis had a significant effect in treating the most common form of multiple sclerosis in a small, short-term clinical trial led by scientists at University of California-San Francisco.
   Similar news · Read more »
   
7. American Thoracic Society publishes new statement on hepatotoxicity of antituberculosis therapy
   11-07-2006 · EurekAlert!
   The American Thoracic Society (ATS) has published a new statement on the pathogenesis, prevention and treatment of liver damage caused by anti-tuberculosis (TB) medications. The statement, which appeared in the October 15 issue of the American Journal of Respiratory and Critical Care Medicine, gives a review of current national and international literature on drug-induced liver injury (DILI) or hepatotoxicity, a potential side effect of more than 700 drugs approved for use in the United States.
   Similar news · Read more »
   
8. Longer term breast feeding protects mother from risk of developing rheumatoid arthritis
   06-15-2007 · EurekAlert!
   Breast feeding for a period of 13 months or more has been shown to reduce the mother's the risk of developing rheumatoid arthritis, according to new data presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain. In the study, the longer the breast feeding period, the lower the mother's risk of developing RA in later life. Comparable use of oral contraceptives or hormone replacement therapy did not show a significant effect on the risk of developing RA.
   Similar news · Read more »
   
9. Silymarin does not affect virus activity or ALT levels in
   02-01-2008 · EurekAlert!
   In a survey of patients with chronic hepatitis C who participated in a National Institute of Diabetes and Digestive and Kidney Diseases-sponsored long-term treatment trial for patients who had failed to respond previously to antiviral therapy, approximately 40 percent acknowledged to interviewers at the time of enrollment that they were currently using or had in the recent past used herbal products for health purposes.
   Similar news · Read more »
   
10. Treatment outcomes of patients with HIV and tuberculosis
    06-01-2007 · EurekAlert!
    In a retrospective study of 700 patients with culture-positive tuberculosis, relapse rates were found to be significantly higher in HIV-infected patients compared to HIV-uninfected patients following a rifamycin-based regimen. Furthermore, TB relapse rates were higher in HIV-infected patients who received intermittent or standard 6-month therapy when compared to those receiving daily or longer treatment.
    Similar news · Read more »